Among these down-regulated molecules, Sanchez Freire et al. [72], in their study, showed a significantly lower expression of neurokinin 1 (NK1) tachykinin receptor in BPS patients than in controls. This evidence concerns the gene TAC1 and Bartsocas-Papas syndrome 1.